Retrieved from Wharton, S., Blevins, T., Connery, L., et al
Limitations of Current Research While the potential anti-inflammatory properties of semaglutide are exciting, there are some limitations: Lack of Direct Evidence for Back Pain: Most studies have focused on semaglutides effects on weight loss and diabetes
J ASEAN Federation Endocr Soc
These medications have created a whole new vocabulary for how people talk about their experiences, leading to terms like Ozempic butt. While these terms are certainly not valid scientific terms, they may indicate certain side effects
Alternatives to semaglutide The following are alternatives to semaglutide: Tirzepatide (Mounjaro and Zepbound) Tirzepatide is a dual GLP-1 and GIP receptor agonist medication